{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:02:16Z","timestamp":1785250936648,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128763","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:34:54Z","timestamp":1780090494000},"page":"128763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Xuejing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Smolders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128763_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1348088","article-title":"COVID-19 vaccine intercountry distribution inequality and its underlying factors: a combined concentration index analysis and multiple linear regression analysis","volume":"12","author":"Abu El Kheir-Mataria","year":"2024","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-021-00323-6","article-title":"Access to and equitable distribution of COVID-19 vaccine in low-income countries","volume":"6","author":"Acharya","year":"2021","journal-title":"npj Vaccines"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128763_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107873118","article-title":"Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination","volume":"118","author":"Agarwal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vaccine.2026.128763_bb0020","series-title":"COVAX explained: to end this global health crisis we don\u2019t just need COVID-19 vaccines, we also need to ensure that everyone in the world has access to them","author":"Berkley","year":"2020"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/oxrep\/grac038","article-title":"Distributing a billion vaccines: COVAX successes, challenges, and opportunities","volume":"38","author":"Budish","year":"2022","journal-title":"Oxf. Rev. Econ. Policy"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11524-021-00551-0","article-title":"Vaccination disparity: quantifying racial inequity in COVID-19 vaccine administration in Maryland","volume":"98","author":"Cardona","year":"2021","journal-title":"J. Urban Health"},{"key":"10.1016\/j.vaccine.2026.128763_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.113566","article-title":"Improving preparedness for next pandemics: max level of COVID-19 vaccinations without social impositions to design effective health policy and avoid flawed democracies","volume":"213","author":"Coccia","year":"2022","journal-title":"Environ. Res."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11115-022-00661-6","article-title":"COVID-19 vaccination is not a sufficient public policy to face crisis management of next pandemic threats","volume":"23","author":"Coccia","year":"2023","journal-title":"Public Organization Review"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3934\/publichealth.2023012","article-title":"Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency","volume":"10","author":"Coccia","year":"2023","journal-title":"AIMS Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128763_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1108\/IJHG-02-2024-0013","article-title":"Effective health systems facing pandemic crisis: lessons from COVID-19 in Europe for next emergencies","volume":"29","author":"Coccia","year":"2024","journal-title":"International Journal of Health Governance"},{"key":"10.1016\/j.vaccine.2026.128763_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2025.100197","article-title":"Global COVID-19 vaccination challenges: inequity of access and vaccine hesitancy","volume":"6","author":"Dagovetz","year":"2025","journal-title":"Journal of Medicine, Surgery, and Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/vaccines11010011","article-title":"COVID-19 vaccines: how efficient and equitable was the initial vaccination process?","volume":"11","author":"Das","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12992-022-00801-z","article-title":"COVAX, vaccine donations and the politics of global vaccine inequity","volume":"18","author":"de Bengy Puyvall\u00e9e","year":"2022","journal-title":"Glob. Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12939-021-01520-4","article-title":"Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach","volume":"20","author":"de Oliveira","year":"2021","journal-title":"Int. J. Equity Health"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128763_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/1468-0009.12503","article-title":"International collaboration to ensure equitable access to vaccines for COVID-19: the ACT-accelerator and the COVAX facility","volume":"99","author":"Eccleston-Turner","year":"2021","journal-title":"Milbank Q."},{"issue":"4\u20136","key":"10.1016\/j.vaccine.2026.128763_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00281-023-00998-0","article-title":"Causes and costs of global COVID-19 vaccine inequity","volume":"45","author":"Ferranna","year":"2024","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128763_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005347","article-title":"COVID-19 vaccines pricing policy options for low-income and middle-income countries","volume":"6","author":"Guzman","year":"2021","journal-title":"BMJ Glob. Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","article-title":"A global panel database of pandemic policies (Oxford COVID-19 government response tracker)","volume":"5","author":"Hale","year":"2021","journal-title":"Nat. Hum. Behav."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/dewb.12349","article-title":"Charity or empowerment? The role of COVAX for low and middle-income countries","volume":"23","author":"Holzer","year":"2023","journal-title":"Dev World Bioeth"},{"key":"10.1016\/j.vaccine.2026.128763_bb0100","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822001418","article-title":"A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality","volume":"150","author":"Magazzino","year":"2022","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.vaccine.2026.128763_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/ijph.2021.1604236","article-title":"Expert views on COVAX and equitable global access to COVID-19 vaccines","volume":"66","author":"Manriquez Roa","year":"2021","journal-title":"Int J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0110","doi-asserted-by":"crossref","DOI":"10.1080\/27707571.2022.2059201","article-title":"Motivating factors for and barriers to the COVID-19 vaccine uptake: a review of social media data in Zambia","volume":"9","author":"Matenga","year":"2022","journal-title":"Cogent Public Health"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128763_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10081306","article-title":"The race for global equitable access to COVID-19 vaccines","volume":"10","author":"Md Khairi","year":"2022","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128763_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002834","article-title":"The role of global health partnerships in vaccine equity: a scoping review","volume":"4","author":"Nunes","year":"2024","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.vaccine.2026.128763_bb0125","author":"Our World in Data"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128763_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-011881","article-title":"Vaccine access, equity and justice: COVID-19 vaccines and vaccination","volume":"8","author":"Privor-Dumm","year":"2023","journal-title":"BMJ Glob. Health"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128763_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012168","article-title":"A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review","volume":"8","author":"Pushkaran","year":"2023","journal-title":"BMJ Glob. Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3934\/publichealth.2021052","article-title":"The relationship between macro-socioeconomics determinants and COVID-19 vaccine distribution","volume":"8","author":"Roghani","year":"2021","journal-title":"AIMS Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128763_bb0145","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/jamia\/ocab180","article-title":"Interactive, on-line visualization tools to measure and drive equity in COVID-19 vaccine administrations","volume":"28","author":"Shaheen","year":"2021","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.vaccine.2026.128763_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2021.100535","article-title":"Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland","volume":"38","author":"Shattock","year":"2022","journal-title":"Epidemics"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12992-021-00763-8","article-title":"Risky business: COVAX and the financialization of global vaccine equity","volume":"17","author":"Stein","year":"2021","journal-title":"Glob. Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128763_bb0160","doi-asserted-by":"crossref","DOI":"10.1080\/17441692.2021.1987502","article-title":"COVAX and the rise of the \u201csuper public private partnership\u201d for global health","volume":"18","author":"Storeng","year":"2023","journal-title":"Glob Public Health"},{"key":"10.1016\/j.vaccine.2026.128763_bb0165","series-title":"COVID-19 Vaccine market dashboard [Data set]","author":"United Nations Children's Fund","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128763_bb0170","doi-asserted-by":"crossref","DOI":"10.1079\/globalhealthcases.2024.0003","article-title":"Understanding the barriers to equitable access to vaccines: an analysis of COVAX","author":"Upton","year":"2024","journal-title":"Glob Health Cases"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128763_bb0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S0922156523000183","article-title":"The global distribution of COVID-19 vaccines by the public-private partnership COVAX from a public-law perspective","volume":"36","author":"Von Achenbach","year":"2023","journal-title":"Leiden Journal of International Law"},{"key":"10.1016\/j.vaccine.2026.128763_bb0180","author":"World Bank"},{"key":"10.1016\/j.vaccine.2026.128763_bb0185","author":"World Bank"},{"key":"10.1016\/j.vaccine.2026.128763_bb0190","author":"World Bank"},{"key":"10.1016\/j.vaccine.2026.128763_bb0195","author":"World Bank"},{"issue":"05","key":"10.1016\/j.vaccine.2026.128763_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.21.287516","article-title":"COVAX and equitable access to COVID-19 vaccines","volume":"100","author":"Yoo","year":"2022","journal-title":"Bull. World Health Organ."},{"issue":"7","key":"10.1016\/j.vaccine.2026.128763_bb0205","first-page":"2353","article-title":"Inequality in COVID-19 vaccination in Africa","volume":"14","author":"Zbiri","year":"2024","journal-title":"Journal of Public Health in Africa"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:41:06Z","timestamp":1785249666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0264410X26005724"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128763","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128763"}}